27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Troy, Nov. 6, 2014 (GLOBE NEWSWIRE) -- After a hard-fought trial, Etransmedia Technology, Inc. wona decisive victory when an arbitration panel in Raleigh, NorthCarolina ruled that Allscripts Healthcare, LLC(NASDAQ: MDRX), with offices in Chicago, and Raleigh, NC, hadbreached its partner agreement with Etransmedia, and violated theNorth Carolina Unfair and Deceptive Trade Practices Act.
The three-person arbitration panel found thatAllscripts unfairly profited by inducing Etransmedia topre-purchase Allscripts MyWay™ software licenses by assuringEtransmedia that Allscripts would make the product compliant withMedicare law and then failed to do so. Most notably, the Panelruled that Allscripts "deliberately sabotaged" Etransmedia's salesefforts.
Allscripts promoted the fact that its products, including MyWay,designed for small practices, would satisfy government 'meaningfuluse' requirements enacted as part of the Health InformationTechnology for Economic and Clinical Health ("HITECH") Act of2009. On October 5, 2012, however, Allscripts announced thatit was phasing out MyWay.
The following were among the panel's findings:
- Allscripts sought and obtained the benefit of increasing itsfinancial performance numbers by inducing Etransmedia topre-purchase Allscripts MyWay™ licenses by assuring Etransmediathat Allscripts would make MyWay MU2 and ICD-10 compliant and thenfailed to do so.
- Allscripts failed to show that its offer to substitute itsAllscripts Professional product was a commercially reasonableproposition. Allscripts breached the partner agreement, andAllscripts' offer regarding the substitution of Professional forMyWay was not commercially reasonable under the circumstances ofthe case.
- Allscripts assured Etransmedia of its support of MyWay salesthrough a program marketed at Costco Wholesale, and in connectionwith community sales programs. In fact, Allscripts' Sales Teamundertook steps that "deliberately sabotaged Etransmedia's effortsto sell the licenses it had pre-purchased at Allscripts'behest."
Etransmedia had been a reseller of MyWay and also hosted datafor many of its MyWay clients. At the time of Allscripts'October 5, 2012 announcement, Etransmedia's had accumulatedmillions of dollars of inventory in unsold licenses.
Vikram Agrawal, President/CEO of Etransmediacommented on the ruling, "It was a hard-fought victory for acompany of our size against a giant $1.4 billion publicly tradedcompany like Allscripts. We presented the facts, and thearbitration panel concluded that Allscripts took advantage of usthrough its deceptive trade practices. We stood up for whatwe believe, and were proven right."
"We believe this will have a far-reaching impactfor companies like ours," said Vikash Agrawal, Chairman. "Despitethe better part of two years of legal process, and significantcosts, we did not allow this to be a distraction - we continued tofocus on our own growth. We have developed our proprietaryConnect2Care® product suite to strengthen our positionas technology innovators in the healthcare industry."
Partners Thomas Fallati and William J. Keniry,and associate Dana Salazar, attorneys with Tabner, Ryan and Keniry, representedEtransmedia in this case. Commenting on the ruling, Mr. Fallatisaid, "We are obviously thrilled with the Panel's ruling. We workedclosely with our client to present a solid case that was beyonddispute." http://trklaw.com
AboutEtransmedia
Founded in 2000, Etransmedia delivers, software and technologyenabled Revenue Cycle Management services to the healthcareindustry. The innovative and proprietaryConnect2Care®suite delivers a comprehensive software andservice package to ensure financial and clinical results forhealthcare providers. The platform includes; Patient Engagement,Mobile Apps, Care Coordination, Financial Analytics, PracticeManagement, and Electronic Health Records. To learn more: www.etransmedia.com
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!